Open access · CC-BY
via OpenAlex
Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice
Kai Mao, Gabriela Farias Quipildor, Tahmineh Tabrizian, Ardijana Novaj, Fangxia Guan, Ryan O. Walters, Fabien Delahaye, Gene B. Hubbard, Yuji Ikeno, Keisuke Ejima, Peng Li, David B. Allison, Hossein Salimi-Moosavi, Pedro J. Beltran, Pinchas Cohen
Nature Communications · 2018 · ▲ 167 citations
Deregulated nutrient-sensing
Altered intercellular communication
Chronic inflammation
Human
Mouse
Preclinical / animal
Abstract
Diminished growth factor signaling improves longevity in laboratory models, while a reduction in the somatotropic axis is favorably linked to human aging and longevity. Given the conserved role of this pathway on lifespan, therapeutic strategies, such as insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibodies (mAb), represent a promising translational tool to target human aging. To this end, we performed a preclinical study in 18-mo-old male and female mice treated with vehicle or an IGF-1R mAb (L2-Cmu, Amgen Inc), and determined effects on aging outcomes. Here we show that L2-Cmu preferentially improves female healthspan(definition) and increases median lifespan by 9% (P = 0.03) in females, along with a reduction in neoplasms and inflammation (P ≤ 0.05). Thus, consistent with other models, targeting IGF-1R signaling appears to be most beneficial to females. Importantly, these effects could be achieved at advanced ages, suggesting that IGF-1R mAbs could represent a promising therapeutic candidate to delay aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41467-018-04805-5
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Mao, K., Quipildor, G.F., Tabrizian, T., Novaj, A., Guan, F., Walters, R.O., Delahaye, F., Hubbard, G.B., Ikeno, Y., Ejima, K., Li, P., Allison, D.B., Salimi-Moosavi, H., Beltran, P.J., Cohen, P., Barzilai, N., & Huffman, D.M. (2018). Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. <em>Nature Communications</em>. https://doi.org/10.1038/s41467-018-04805-5
Vancouver
Mao K, Quipildor GF, Tabrizian T, Novaj A, Guan F, Walters RO, et al. Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nature Communications. 2018. doi:10.1038/s41467-018-04805-5.
BibTeX
@article{kai2018Lateli,
title = {Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice},
author = {Kai Mao and Gabriela Farias Quipildor and Tahmineh Tabrizian and Ardijana Novaj and Fangxia Guan and Ryan O. Walters and Fabien Delahaye and Gene B. Hubbard and Yuji Ikeno and Keisuke Ejima and Peng Li and David B. Allison and Hossein Salimi-Moosavi and Pedro J. Beltran and Pinchas Cohen and Nir Barzilai and Derek M. Huffman},
journal = {Nature Communications},
year = {2018},
doi = {10.1038/s41467-018-04805-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Longevity & Healthspan 2014
Open access · CC-BY
Mitochondrial oxidative stress in aging and healthspan
Aging Cell 2008
Citation only
Impact of reduced insulin‐like growth factor‐1/insulin signaling on aging in mammals: novel findings
Cell Cycle 2008
Open access · OA
Insulin and aging
Journal of Aging Research 2011
Open access · CC-BY
Lifespan and Glucose Metabolism in Insulin Receptor Mutant Mice
PLoS ONE 2011
Open access · CC-BY
Does Reduced IGF-1R Signaling in Igf1r+/− Mice Alter Aging?
Aging Cell 2025
Open access · CC-BY